Compounded Semaglutide

In the STEP 1 trial published in The New England Journal of Medicine (Wilding et al., 2021), participants on weekly 2.4 mg semaglutide lost an average of 14.9% of body weight at 68 weeks versus 2.4% on placebo. Most patients see meaningful changes after 8–12 weeks as the dose titrates up. Individual results vary based on dose, adherence, diet, and physical activity.

No specific diet is required, but moderate calorie reduction and adequate protein intake meaningfully improve outcomes. Many patients find their appetite naturally drops, which makes a balanced diet easier to sustain. Your care team can provide nutrition guidance during your protocol.

Published data (STEP 4 trial, JAMA 2022) show that most patients regain a portion of lost weight after discontinuation. Long-term success typically involves either continued treatment, transition to a maintenance dose, or a structured lifestyle plan, discussed with your doctor toward the end of your active titration.

Moderate alcohol is not contraindicated, but semaglutide can amplify alcohol's effects on blood sugar and on the gut. Patients commonly report a reduced desire to drink. Avoid heavy drinking, especially during dose increases.

Peptide12 partners with state-licensed compounding pharmacies that hold state and federal licensure and undergo regular USP <797> sterility audits. Every batch is third-party tested for identity, potency, sterility, and endotoxin before release.

Yes. Basic baseline labs (metabolic panel, HbA1c, lipid panel, thyroid panel) are reviewed by your prescribing doctor before a prescription is issued. If you have recent labs (within 12 months), you can upload them; otherwise we coordinate at-home or in-network draws.

If you miss a dose by fewer than 5 days, take it as soon as you remember and resume your normal weekly schedule. If more than 5 days have passed, skip the missed dose and resume at your next scheduled day. Never double-dose. Message your care team if you are unsure.

In most cases, yes. Your doctor will convert your current dose to an equivalent compounded dose with no titration restart required. Transitions in either direction are common.

Compounded medications are typically not covered by commercial insurance. Many patients use HSA or FSA funds. Branded options (Wegovy, Ozempic, Zepbound) may be covered with prior authorization. Your care team can help you check eligibility.